Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetate kinase is an enzyme broadly distributed in Bacteria and Archaea, responsible for catalyzing the reversible transfer of a phosphate group from ATP to acetate, yielding acetyl phosphate and ADP[1][2][4]. This reaction is a key step in acetate metabolism, especially in anaerobic microbial pathways, and is vital for energy production and the regulation of carbon flow[4][5][6][7]. Acetate kinase belongs to the ASKHA superfamily of phosphotransferases, sharing structural similarities with other enzymes like glycerol kinase and hexokinase[1][2][3]. It typically forms functional oligomers (dimers), with its activity and structure characterized by conserved ADP-binding domains and key active-site residues[1][2][3]. In bacteria such as Escherichia coli, acetate kinase is essential for acetate utilization, energy balance, and adaptation to varying environmental conditions[6]. The enzyme is not currently recognized as a direct therapeutic target, but its role in microbial metabolism makes it important in contexts such as infectious disease and microbiome research[4][5][7]. No incorrect or ambiguous information was identified for "Acetate kinase" as a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetate kinase.